NCT06502041

Brief Summary

This study compares the effect of MARPE (mini-implant assisted rapid palatal expansion) versus MARPE+ MOP (Micro-osteo-perforation) on nasal airway and maxillary transverse deficiency in non-growing patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 15, 2024

Completed
Last Updated

July 15, 2024

Status Verified

July 1, 2024

Enrollment Period

1.3 years

First QC Date

July 8, 2024

Last Update Submit

July 13, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Number of days till diastema appearance

    (days)

    about 1 month

  • Amount of skeletal expansion

    (mm)

    about 1 month

  • Pain experience during activation of expander by visual analogue scale ( VAS)

    VAS: 0 ( no pain), 10 (unbearable pain)

    about 1 months

  • Skeletal, Dental & Nasal readings

    from CBCT and scanned models measured in degrees \& mm

    measured before treatment and after 6 month of treatment

  • Stability of correction of transverse deficiency

    by measuring the same CBCT transverse reading and by superimposition of the scaneed models at the end of the research

    about 6 months

Study Arms (2)

MARPE with MOP

EXPERIMENTAL
Procedure: MARPE with MOP

MARPE without MOP

ACTIVE COMPARATOR
Procedure: MARPE without MOP

Interventions

mini-screw assisted rapid palatal expansion with micro-osteoperforation

MARPE with MOP

mini-screw assisted rapid palatal expansion without micro-osteoperforation

MARPE without MOP

Eligibility Criteria

Age20 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The age ranges from 20-25 years.
  • Post pubertal adolescent
  • Skeletal transverse deficiency with unilateral or bilateral cross-bite
  • Extraction is not indicated in the lower arch.
  • Upper permanent dentition is erupted up to the second molars.
  • Average facial vertical growth pattern.
  • Space deficiency in the upper arch is less than 8 mm

You may not qualify if:

  • Diseases and medications those are likely to affect bone biology.
  • Evidence of root resorption.
  • Poor oral hygiene.
  • Previous orthodontic treatment.
  • Evidence of bone loss.
  • Active periodontal disease.
  • Craniofacial congenital anomalies, such as cleft lip and palate.
  • \. Pregnant females. 8. Presence of oral habits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, Adakhlia, Egypt

Location

Related Publications (1)

  • Elshehaby M, Albelasy NF, Elbialy MA, Hafez AM, Abdelnaby YL. Evaluation of pain intensity and airway changes in non-growing patients treated by MARPE with and without micro-osteoperforation: a randomized clinical trial. BMC Oral Health. 2024 Nov 20;24(1):1411. doi: 10.1186/s12903-024-05196-4.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of either patient or clinician is not possible. However, blinding was ensured during analyzing the data. All digital models and x-rays were coded and shuffled before they were evaluated and measured.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 8, 2024

First Posted

July 15, 2024

Study Start

September 5, 2022

Primary Completion

January 3, 2024

Study Completion

July 3, 2024

Last Updated

July 15, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

the published results

Locations